AI assistant
Sending…
PAVmed Inc. — Director's Dealing 2016
Jan 29, 2016
35221_dirs_2016-01-29_e2889847-7b5f-4f9c-99d6-c4d0da26e063.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2016-01-29
Reporting Person: Greenspan Ira Scott (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 27873 | Direct |
| Common Stock | 5713879 | Indirect |
| Common Stock | 20904 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrant | $5.00 | 2021-11-25 | Common Stock (27837) | Direct | |
| Warrant | $5.00 | 2021-11-25 | Common Stock (5713879) | Indirect | |
| Warrant | $5.00 | 2021-11-25 | Common Stock (20904) | Indirect |
Footnotes
F1: Mr. Greenspan is a member and co-manager of HCFP/Capital Partners III LLC, and shares joint voting and dispositive power over the shares held by this entity. Mr. Greenspan disclaims beneficial ownership of shares held by this entity, except to the extent of their proportionate pecuniary interest therein.
F2: Robert M. Greenspan is the Reporting Person's son.
F3: The warrants will be exercisable commencing 6 months from the consummation of the Issuer's initial public offering.
More from PAVmed Inc.
Earnings Release
2026
May 15
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 1
Annual Report
2026
Apr 30
Earnings Release
2026
Mar 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Feb 24
Regulatory Filings
2026
Feb 17
Capital/Financing Update
2026
Feb 4
Regulatory Filings
2026
Jan 23